LYSIS PHARMA

About LYSIS PHARMA

We are currently looking for opportunities for CRO, CRAMS and API intermediates businesses to become trusted partners for the global clients towards their innovative research needs and drug development/Generic programs. Lysis has strong operational expertise in Ø Alkylation / Arylation (Both aliphatic and aromatic) Ø Brominations Ø Grignard Reactions Ø Cyanations, Phosgenations Ø Gen...

  • US
  • 2022
    On CPHI since